nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—CYP2C9—Donepezil—Alzheimer's disease	0.21	1	CbGbCtD
Glimepiride—KCNJ1—forebrain—Alzheimer's disease	0.0114	0.147	CbGeAlD
Glimepiride—KCNJ1—telencephalon—Alzheimer's disease	0.0105	0.135	CbGeAlD
Glimepiride—ABCC8—ABC-family proteins mediated transport—ABCA7—Alzheimer's disease	0.00805	0.0938	CbGpPWpGaD
Glimepiride—ABCC8—forebrain—Alzheimer's disease	0.00638	0.0822	CbGeAlD
Glimepiride—KCNJ1—nervous system—Alzheimer's disease	0.0062	0.0799	CbGeAlD
Glimepiride—KCNJ1—central nervous system—Alzheimer's disease	0.00597	0.0769	CbGeAlD
Glimepiride—ABCC8—telencephalon—Alzheimer's disease	0.00587	0.0756	CbGeAlD
Glimepiride—KCNJ1—brain—Alzheimer's disease	0.00474	0.0611	CbGeAlD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—TTR—Alzheimer's disease	0.00424	0.0493	CbGpPWpGaD
Glimepiride—Glyburide—ABCA1—Alzheimer's disease	0.00419	0.325	CrCbGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—TTR—Alzheimer's disease	0.00411	0.0478	CbGpPWpGaD
Glimepiride—Gliclazide—VEGFA—Alzheimer's disease	0.00399	0.31	CrCbGaD
Glimepiride—KCNJ11—nervous system—Alzheimer's disease	0.00376	0.0485	CbGeAlD
Glimepiride—KCNJ11—central nervous system—Alzheimer's disease	0.00362	0.0467	CbGeAlD
Glimepiride—KCNJ11—cerebellum—Alzheimer's disease	0.00354	0.0456	CbGeAlD
Glimepiride—ABCC8—nervous system—Alzheimer's disease	0.00347	0.0446	CbGeAlD
Glimepiride—Pain in extremity—Galantamine—Alzheimer's disease	0.00342	0.00558	CcSEcCtD
Glimepiride—ABCC8—central nervous system—Alzheimer's disease	0.00334	0.043	CbGeAlD
Glimepiride—Vasculitis—Rivastigmine—Alzheimer's disease	0.00332	0.00542	CcSEcCtD
Glimepiride—ABCC8—cerebellum—Alzheimer's disease	0.00326	0.042	CbGeAlD
Glimepiride—Glipizide—PPARG—Alzheimer's disease	0.00306	0.238	CrCbGaD
Glimepiride—Diabetes mellitus—Donepezil—Alzheimer's disease	0.00305	0.00497	CcSEcCtD
Glimepiride—Coma—Memantine—Alzheimer's disease	0.00303	0.00494	CcSEcCtD
Glimepiride—Coma—Rivastigmine—Alzheimer's disease	0.00297	0.00483	CcSEcCtD
Glimepiride—Haemolytic anaemia—Donepezil—Alzheimer's disease	0.00294	0.00479	CcSEcCtD
Glimepiride—Injury—Donepezil—Alzheimer's disease	0.00289	0.0047	CcSEcCtD
Glimepiride—Mental disability—Memantine—Alzheimer's disease	0.00288	0.00469	CcSEcCtD
Glimepiride—KCNJ11—brain—Alzheimer's disease	0.00288	0.037	CbGeAlD
Glimepiride—Hot flush—Donepezil—Alzheimer's disease	0.00283	0.00462	CcSEcCtD
Glimepiride—Increased appetite—Donepezil—Alzheimer's disease	0.00282	0.0046	CcSEcCtD
Glimepiride—Mental disability—Rivastigmine—Alzheimer's disease	0.00282	0.00459	CcSEcCtD
Glimepiride—Menopausal symptoms—Donepezil—Alzheimer's disease	0.00281	0.00458	CcSEcCtD
Glimepiride—Dermatitis bullous—Donepezil—Alzheimer's disease	0.00277	0.00452	CcSEcCtD
Glimepiride—Diabetes mellitus—Memantine—Alzheimer's disease	0.00277	0.00451	CcSEcCtD
Glimepiride—Hepatic function abnormal—Memantine—Alzheimer's disease	0.00276	0.00449	CcSEcCtD
Glimepiride—Pollakiuria—Galantamine—Alzheimer's disease	0.00273	0.00445	CcSEcCtD
Glimepiride—Hypoglycaemia—Donepezil—Alzheimer's disease	0.00272	0.00443	CcSEcCtD
Glimepiride—Diabetes mellitus—Rivastigmine—Alzheimer's disease	0.00271	0.00441	CcSEcCtD
Glimepiride—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.00271	0.00441	CcSEcCtD
Glimepiride—Hepatic failure—Memantine—Alzheimer's disease	0.00268	0.00437	CcSEcCtD
Glimepiride—Hyponatraemia—Donepezil—Alzheimer's disease	0.00266	0.00434	CcSEcCtD
Glimepiride—ABCC8—brain—Alzheimer's disease	0.00265	0.0341	CbGeAlD
Glimepiride—Injury—Memantine—Alzheimer's disease	0.00262	0.00427	CcSEcCtD
Glimepiride—Hot flush—Memantine—Alzheimer's disease	0.00257	0.00419	CcSEcCtD
Glimepiride—Increased appetite—Memantine—Alzheimer's disease	0.00256	0.00418	CcSEcCtD
Glimepiride—Injury—Rivastigmine—Alzheimer's disease	0.00256	0.00418	CcSEcCtD
Glimepiride—Menopausal symptoms—Memantine—Alzheimer's disease	0.00255	0.00416	CcSEcCtD
Glimepiride—Dermatitis bullous—Memantine—Alzheimer's disease	0.00252	0.0041	CcSEcCtD
Glimepiride—Hot flush—Rivastigmine—Alzheimer's disease	0.00252	0.0041	CcSEcCtD
Glimepiride—Increased appetite—Rivastigmine—Alzheimer's disease	0.00251	0.00408	CcSEcCtD
Glimepiride—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.0025	0.00407	CcSEcCtD
Glimepiride—Hypoglycaemia—Memantine—Alzheimer's disease	0.00247	0.00402	CcSEcCtD
Glimepiride—Dermatitis bullous—Rivastigmine—Alzheimer's disease	0.00246	0.00402	CcSEcCtD
Glimepiride—Cerebrovascular accident—Memantine—Alzheimer's disease	0.00246	0.004	CcSEcCtD
Glimepiride—Hyponatraemia—Memantine—Alzheimer's disease	0.00242	0.00394	CcSEcCtD
Glimepiride—Hypoglycaemia—Rivastigmine—Alzheimer's disease	0.00241	0.00393	CcSEcCtD
Glimepiride—Bradycardia—Galantamine—Alzheimer's disease	0.00241	0.00393	CcSEcCtD
Glimepiride—Pain in extremity—Memantine—Alzheimer's disease	0.00241	0.00392	CcSEcCtD
Glimepiride—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.0024	0.00392	CcSEcCtD
Glimepiride—Hepatitis—Galantamine—Alzheimer's disease	0.00237	0.00386	CcSEcCtD
Glimepiride—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.00237	0.00385	CcSEcCtD
Glimepiride—Pain in extremity—Rivastigmine—Alzheimer's disease	0.00236	0.00384	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Donepezil—Alzheimer's disease	0.00234	0.00381	CcSEcCtD
Glimepiride—Abdominal distension—Donepezil—Alzheimer's disease	0.00231	0.00376	CcSEcCtD
Glimepiride—Influenza—Donepezil—Alzheimer's disease	0.00229	0.00373	CcSEcCtD
Glimepiride—Visual impairment—Galantamine—Alzheimer's disease	0.00228	0.00372	CcSEcCtD
Glimepiride—Eosinophilia—Donepezil—Alzheimer's disease	0.00227	0.0037	CcSEcCtD
Glimepiride—Angina pectoris—Donepezil—Alzheimer's disease	0.00223	0.00364	CcSEcCtD
Glimepiride—Sweating increased—Donepezil—Alzheimer's disease	0.00223	0.00364	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Memantine—Alzheimer's disease	0.00212	0.00346	CcSEcCtD
Glimepiride—Pollakiuria—Donepezil—Alzheimer's disease	0.00212	0.00345	CcSEcCtD
Glimepiride—Arrhythmia—Galantamine—Alzheimer's disease	0.00211	0.00345	CcSEcCtD
Glimepiride—Weight increased—Donepezil—Alzheimer's disease	0.00209	0.0034	CcSEcCtD
Glimepiride—Influenza—Memantine—Alzheimer's disease	0.00208	0.00339	CcSEcCtD
Glimepiride—Malnutrition—Galantamine—Alzheimer's disease	0.00206	0.00336	CcSEcCtD
Glimepiride—Sweating increased—Memantine—Alzheimer's disease	0.00203	0.0033	CcSEcCtD
Glimepiride—Angina pectoris—Memantine—Alzheimer's disease	0.00203	0.0033	CcSEcCtD
Glimepiride—Tension—Galantamine—Alzheimer's disease	0.00202	0.00329	CcSEcCtD
Glimepiride—Nervousness—Galantamine—Alzheimer's disease	0.002	0.00326	CcSEcCtD
Glimepiride—Jaundice—Donepezil—Alzheimer's disease	0.00199	0.00325	CcSEcCtD
Glimepiride—Sweating increased—Rivastigmine—Alzheimer's disease	0.00198	0.00323	CcSEcCtD
Glimepiride—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00198	0.00323	CcSEcCtD
Glimepiride—Pancytopenia—Memantine—Alzheimer's disease	0.00198	0.00322	CcSEcCtD
Glimepiride—Sweating—Donepezil—Alzheimer's disease	0.00196	0.00319	CcSEcCtD
Glimepiride—Vision blurred—Galantamine—Alzheimer's disease	0.00194	0.00316	CcSEcCtD
Glimepiride—Tremor—Galantamine—Alzheimer's disease	0.00193	0.00315	CcSEcCtD
Glimepiride—Pollakiuria—Memantine—Alzheimer's disease	0.00192	0.00313	CcSEcCtD
Glimepiride—Anaemia—Galantamine—Alzheimer's disease	0.0019	0.0031	CcSEcCtD
Glimepiride—Weight increased—Memantine—Alzheimer's disease	0.00189	0.00309	CcSEcCtD
Glimepiride—Agitation—Galantamine—Alzheimer's disease	0.00189	0.00309	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—SLC18A3—Alzheimer's disease	0.00189	0.022	CbGpPWpGaD
Glimepiride—Pollakiuria—Rivastigmine—Alzheimer's disease	0.00188	0.00306	CcSEcCtD
Glimepiride—Bradycardia—Donepezil—Alzheimer's disease	0.00187	0.00304	CcSEcCtD
Glimepiride—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.00186	0.00303	CcSEcCtD
Glimepiride—Weight increased—Rivastigmine—Alzheimer's disease	0.00185	0.00302	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.00184	0.003	CcSEcCtD
Glimepiride—Hepatitis—Donepezil—Alzheimer's disease	0.00183	0.00299	CcSEcCtD
Glimepiride—Palpitations—Galantamine—Alzheimer's disease	0.00182	0.00297	CcSEcCtD
Glimepiride—Drowsiness—Rivastigmine—Alzheimer's disease	0.00182	0.00296	CcSEcCtD
Glimepiride—Loss of consciousness—Galantamine—Alzheimer's disease	0.00181	0.00295	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.0018	0.00293	CcSEcCtD
Glimepiride—Convulsion—Galantamine—Alzheimer's disease	0.00179	0.00291	CcSEcCtD
Glimepiride—Hypertension—Galantamine—Alzheimer's disease	0.00178	0.0029	CcSEcCtD
Glimepiride—Visual impairment—Donepezil—Alzheimer's disease	0.00177	0.00288	CcSEcCtD
Glimepiride—Anxiety—Galantamine—Alzheimer's disease	0.00175	0.00285	CcSEcCtD
Glimepiride—Sweating—Rivastigmine—Alzheimer's disease	0.00174	0.00284	CcSEcCtD
Glimepiride—Agranulocytosis—Memantine—Alzheimer's disease	0.00173	0.00282	CcSEcCtD
Glimepiride—Dry mouth—Galantamine—Alzheimer's disease	0.00172	0.0028	CcSEcCtD
Glimepiride—Confusional state—Galantamine—Alzheimer's disease	0.0017	0.00276	CcSEcCtD
Glimepiride—Bradycardia—Memantine—Alzheimer's disease	0.0017	0.00276	CcSEcCtD
Glimepiride—Hepatitis—Memantine—Alzheimer's disease	0.00167	0.00271	CcSEcCtD
Glimepiride—Bradycardia—Rivastigmine—Alzheimer's disease	0.00166	0.0027	CcSEcCtD
Glimepiride—Shock—Galantamine—Alzheimer's disease	0.00165	0.0027	CcSEcCtD
Glimepiride—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00165	0.00268	CcSEcCtD
Glimepiride—Tachycardia—Galantamine—Alzheimer's disease	0.00164	0.00267	CcSEcCtD
Glimepiride—Arrhythmia—Donepezil—Alzheimer's disease	0.00164	0.00267	CcSEcCtD
Glimepiride—Chlorpropamide—PTGS1—Alzheimer's disease	0.00164	0.127	CrCbGaD
Glimepiride—Hepatitis—Rivastigmine—Alzheimer's disease	0.00163	0.00265	CcSEcCtD
Glimepiride—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00163	0.00265	CcSEcCtD
Glimepiride—Visual impairment—Memantine—Alzheimer's disease	0.00161	0.00262	CcSEcCtD
Glimepiride—Anorexia—Galantamine—Alzheimer's disease	0.0016	0.00261	CcSEcCtD
Glimepiride—Malnutrition—Donepezil—Alzheimer's disease	0.0016	0.0026	CcSEcCtD
Glimepiride—Erythema—Donepezil—Alzheimer's disease	0.0016	0.0026	CcSEcCtD
Glimepiride—Erythema multiforme—Memantine—Alzheimer's disease	0.00157	0.00257	CcSEcCtD
Glimepiride—Hypotension—Galantamine—Alzheimer's disease	0.00157	0.00256	CcSEcCtD
Glimepiride—Visual impairment—Rivastigmine—Alzheimer's disease	0.00157	0.00256	CcSEcCtD
Glimepiride—Tension—Donepezil—Alzheimer's disease	0.00157	0.00255	CcSEcCtD
Glimepiride—Nervousness—Donepezil—Alzheimer's disease	0.00155	0.00253	CcSEcCtD
Glimepiride—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.00154	0.00251	CcSEcCtD
Glimepiride—Insomnia—Galantamine—Alzheimer's disease	0.00152	0.00248	CcSEcCtD
Glimepiride—Paraesthesia—Galantamine—Alzheimer's disease	0.00151	0.00246	CcSEcCtD
Glimepiride—Vision blurred—Donepezil—Alzheimer's disease	0.00151	0.00245	CcSEcCtD
Glimepiride—Tremor—Donepezil—Alzheimer's disease	0.0015	0.00244	CcSEcCtD
Glimepiride—Somnolence—Galantamine—Alzheimer's disease	0.0015	0.00244	CcSEcCtD
Glimepiride—Arrhythmia—Memantine—Alzheimer's disease	0.00149	0.00242	CcSEcCtD
Glimepiride—Dyspepsia—Galantamine—Alzheimer's disease	0.00148	0.00241	CcSEcCtD
Glimepiride—Anaemia—Donepezil—Alzheimer's disease	0.00148	0.0024	CcSEcCtD
Glimepiride—Agitation—Donepezil—Alzheimer's disease	0.00147	0.00239	CcSEcCtD
Glimepiride—Decreased appetite—Galantamine—Alzheimer's disease	0.00146	0.00238	CcSEcCtD
Glimepiride—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00146	0.00237	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00145	0.00237	CcSEcCtD
Glimepiride—Malnutrition—Memantine—Alzheimer's disease	0.00145	0.00236	CcSEcCtD
Glimepiride—Fatigue—Galantamine—Alzheimer's disease	0.00145	0.00236	CcSEcCtD
Glimepiride—CYP2C9—CYP2E1 reactions—CYP2D6—Alzheimer's disease	0.00145	0.0168	CbGpPWpGaD
Glimepiride—Tension—Memantine—Alzheimer's disease	0.00142	0.00232	CcSEcCtD
Glimepiride—Malnutrition—Rivastigmine—Alzheimer's disease	0.00142	0.00231	CcSEcCtD
Glimepiride—Erythema—Rivastigmine—Alzheimer's disease	0.00142	0.00231	CcSEcCtD
Glimepiride—Nervousness—Memantine—Alzheimer's disease	0.00141	0.00229	CcSEcCtD
Glimepiride—Loss of consciousness—Donepezil—Alzheimer's disease	0.0014	0.00229	CcSEcCtD
Glimepiride—Tension—Rivastigmine—Alzheimer's disease	0.00139	0.00227	CcSEcCtD
Glimepiride—Feeling abnormal—Galantamine—Alzheimer's disease	0.00139	0.00226	CcSEcCtD
Glimepiride—Convulsion—Donepezil—Alzheimer's disease	0.00138	0.00225	CcSEcCtD
Glimepiride—Hypertension—Donepezil—Alzheimer's disease	0.00138	0.00225	CcSEcCtD
Glimepiride—Nervousness—Rivastigmine—Alzheimer's disease	0.00138	0.00224	CcSEcCtD
Glimepiride—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00138	0.00224	CcSEcCtD
Glimepiride—Vision blurred—Memantine—Alzheimer's disease	0.00137	0.00223	CcSEcCtD
Glimepiride—Tremor—Memantine—Alzheimer's disease	0.00136	0.00221	CcSEcCtD
Glimepiride—Anxiety—Donepezil—Alzheimer's disease	0.00135	0.00221	CcSEcCtD
Glimepiride—CYP2C9—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.00134	0.0156	CbGpPWpGaD
Glimepiride—Anaemia—Memantine—Alzheimer's disease	0.00134	0.00218	CcSEcCtD
Glimepiride—Vision blurred—Rivastigmine—Alzheimer's disease	0.00134	0.00218	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—CHRNA7—Alzheimer's disease	0.00133	0.0155	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—GRIK1—Alzheimer's disease	0.00133	0.0155	CbGpPWpGaD
Glimepiride—Agitation—Memantine—Alzheimer's disease	0.00133	0.00217	CcSEcCtD
Glimepiride—Dry mouth—Donepezil—Alzheimer's disease	0.00133	0.00217	CcSEcCtD
Glimepiride—Abdominal pain—Galantamine—Alzheimer's disease	0.00133	0.00217	CcSEcCtD
Glimepiride—Tremor—Rivastigmine—Alzheimer's disease	0.00133	0.00217	CcSEcCtD
Glimepiride—Confusional state—Donepezil—Alzheimer's disease	0.00131	0.00214	CcSEcCtD
Glimepiride—Anaemia—Rivastigmine—Alzheimer's disease	0.00131	0.00214	CcSEcCtD
Glimepiride—Agitation—Rivastigmine—Alzheimer's disease	0.0013	0.00212	CcSEcCtD
Glimepiride—Leukopenia—Memantine—Alzheimer's disease	0.0013	0.00211	CcSEcCtD
Glimepiride—Shock—Donepezil—Alzheimer's disease	0.00128	0.00209	CcSEcCtD
Glimepiride—Palpitations—Memantine—Alzheimer's disease	0.00128	0.00209	CcSEcCtD
Glimepiride—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00128	0.00208	CcSEcCtD
Glimepiride—Loss of consciousness—Memantine—Alzheimer's disease	0.00127	0.00208	CcSEcCtD
Glimepiride—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00126	0.00205	CcSEcCtD
Glimepiride—Convulsion—Memantine—Alzheimer's disease	0.00126	0.00205	CcSEcCtD
Glimepiride—Palpitations—Rivastigmine—Alzheimer's disease	0.00125	0.00204	CcSEcCtD
Glimepiride—Hypertension—Memantine—Alzheimer's disease	0.00125	0.00204	CcSEcCtD
Glimepiride—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00125	0.00203	CcSEcCtD
Glimepiride—Anorexia—Donepezil—Alzheimer's disease	0.00124	0.00202	CcSEcCtD
Glimepiride—Hypersensitivity—Galantamine—Alzheimer's disease	0.00124	0.00202	CcSEcCtD
Glimepiride—Anxiety—Memantine—Alzheimer's disease	0.00123	0.002	CcSEcCtD
Glimepiride—Convulsion—Rivastigmine—Alzheimer's disease	0.00123	0.002	CcSEcCtD
Glimepiride—Hypertension—Rivastigmine—Alzheimer's disease	0.00122	0.002	CcSEcCtD
Glimepiride—Hypotension—Donepezil—Alzheimer's disease	0.00122	0.00198	CcSEcCtD
Glimepiride—Dry mouth—Memantine—Alzheimer's disease	0.00121	0.00197	CcSEcCtD
Glimepiride—Asthenia—Galantamine—Alzheimer's disease	0.00121	0.00197	CcSEcCtD
Glimepiride—Anxiety—Rivastigmine—Alzheimer's disease	0.0012	0.00196	CcSEcCtD
Glimepiride—Confusional state—Memantine—Alzheimer's disease	0.00119	0.00194	CcSEcCtD
Glimepiride—Dry mouth—Rivastigmine—Alzheimer's disease	0.00118	0.00192	CcSEcCtD
Glimepiride—Insomnia—Donepezil—Alzheimer's disease	0.00118	0.00192	CcSEcCtD
Glimepiride—Paraesthesia—Donepezil—Alzheimer's disease	0.00117	0.00191	CcSEcCtD
Glimepiride—Confusional state—Rivastigmine—Alzheimer's disease	0.00117	0.0019	CcSEcCtD
Glimepiride—Shock—Memantine—Alzheimer's disease	0.00116	0.0019	CcSEcCtD
Glimepiride—Dyspnoea—Donepezil—Alzheimer's disease	0.00116	0.00189	CcSEcCtD
Glimepiride—Somnolence—Donepezil—Alzheimer's disease	0.00116	0.00189	CcSEcCtD
Glimepiride—Thrombocytopenia—Memantine—Alzheimer's disease	0.00116	0.00189	CcSEcCtD
Glimepiride—Tachycardia—Memantine—Alzheimer's disease	0.00116	0.00188	CcSEcCtD
Glimepiride—Diarrhoea—Galantamine—Alzheimer's disease	0.00115	0.00187	CcSEcCtD
Glimepiride—Dyspepsia—Donepezil—Alzheimer's disease	0.00115	0.00187	CcSEcCtD
Glimepiride—Hyperhidrosis—Memantine—Alzheimer's disease	0.00114	0.00186	CcSEcCtD
Glimepiride—Shock—Rivastigmine—Alzheimer's disease	0.00114	0.00186	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—CHAT—Alzheimer's disease	0.00113	0.0132	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—GRIK2—Alzheimer's disease	0.00113	0.0132	CbGpPWpGaD
Glimepiride—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00113	0.00185	CcSEcCtD
Glimepiride—Decreased appetite—Donepezil—Alzheimer's disease	0.00113	0.00185	CcSEcCtD
Glimepiride—Tachycardia—Rivastigmine—Alzheimer's disease	0.00113	0.00184	CcSEcCtD
Glimepiride—Anorexia—Memantine—Alzheimer's disease	0.00113	0.00184	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00113	0.00183	CcSEcCtD
Glimepiride—Fatigue—Donepezil—Alzheimer's disease	0.00112	0.00183	CcSEcCtD
Glimepiride—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00112	0.00182	CcSEcCtD
Glimepiride—Dizziness—Galantamine—Alzheimer's disease	0.00111	0.00181	CcSEcCtD
Glimepiride—Hypotension—Memantine—Alzheimer's disease	0.00111	0.0018	CcSEcCtD
Glimepiride—Anorexia—Rivastigmine—Alzheimer's disease	0.0011	0.0018	CcSEcCtD
Glimepiride—Hypotension—Rivastigmine—Alzheimer's disease	0.00108	0.00176	CcSEcCtD
Glimepiride—Feeling abnormal—Donepezil—Alzheimer's disease	0.00107	0.00175	CcSEcCtD
Glimepiride—Insomnia—Memantine—Alzheimer's disease	0.00107	0.00174	CcSEcCtD
Glimepiride—Vomiting—Galantamine—Alzheimer's disease	0.00107	0.00174	CcSEcCtD
Glimepiride—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00107	0.00174	CcSEcCtD
Glimepiride—Paraesthesia—Memantine—Alzheimer's disease	0.00106	0.00173	CcSEcCtD
Glimepiride—Rash—Galantamine—Alzheimer's disease	0.00106	0.00173	CcSEcCtD
Glimepiride—Dermatitis—Galantamine—Alzheimer's disease	0.00106	0.00173	CcSEcCtD
Glimepiride—Dyspnoea—Memantine—Alzheimer's disease	0.00106	0.00172	CcSEcCtD
Glimepiride—Headache—Galantamine—Alzheimer's disease	0.00105	0.00172	CcSEcCtD
Glimepiride—Somnolence—Memantine—Alzheimer's disease	0.00105	0.00171	CcSEcCtD
Glimepiride—Insomnia—Rivastigmine—Alzheimer's disease	0.00105	0.00171	CcSEcCtD
Glimepiride—Dyspepsia—Memantine—Alzheimer's disease	0.00104	0.0017	CcSEcCtD
Glimepiride—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00104	0.00169	CcSEcCtD
Glimepiride—Urticaria—Donepezil—Alzheimer's disease	0.00104	0.00169	CcSEcCtD
Glimepiride—ABCC8—Regulation of insulin secretion—PLCB1—Alzheimer's disease	0.00103	0.012	CbGpPWpGaD
Glimepiride—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00103	0.00168	CcSEcCtD
Glimepiride—Abdominal pain—Donepezil—Alzheimer's disease	0.00103	0.00168	CcSEcCtD
Glimepiride—Somnolence—Rivastigmine—Alzheimer's disease	0.00103	0.00168	CcSEcCtD
Glimepiride—Decreased appetite—Memantine—Alzheimer's disease	0.00103	0.00168	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00102	0.00166	CcSEcCtD
Glimepiride—Fatigue—Memantine—Alzheimer's disease	0.00102	0.00166	CcSEcCtD
Glimepiride—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00102	0.00166	CcSEcCtD
Glimepiride—KCNJ11—Type II diabetes mellitus—MAPK8—Alzheimer's disease	0.00102	0.0119	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—GRIA1—Alzheimer's disease	0.00101	0.0118	CbGpPWpGaD
Glimepiride—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00101	0.00164	CcSEcCtD
Glimepiride—KCNJ11—Regulation of insulin secretion—PLCB1—Alzheimer's disease	0.001	0.0117	CbGpPWpGaD
Glimepiride—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.001	0.00163	CcSEcCtD
Glimepiride—Nausea—Galantamine—Alzheimer's disease	0.000999	0.00163	CcSEcCtD
Glimepiride—Fatigue—Rivastigmine—Alzheimer's disease	0.000998	0.00163	CcSEcCtD
Glimepiride—Feeling abnormal—Memantine—Alzheimer's disease	0.000975	0.00159	CcSEcCtD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—F2—Alzheimer's disease	0.000973	0.0113	CbGpPWpGaD
Glimepiride—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000968	0.00158	CcSEcCtD
Glimepiride—ABCC8—Neuronal System—SLC18A3—Alzheimer's disease	0.000967	0.0113	CbGpPWpGaD
Glimepiride—Hypersensitivity—Donepezil—Alzheimer's disease	0.00096	0.00156	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—CHRNB2—Alzheimer's disease	0.000957	0.0111	CbGpPWpGaD
Glimepiride—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000954	0.00155	CcSEcCtD
Glimepiride—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000947	0.00154	CcSEcCtD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—F2—Alzheimer's disease	0.000943	0.011	CbGpPWpGaD
Glimepiride—Urticaria—Memantine—Alzheimer's disease	0.00094	0.00153	CcSEcCtD
Glimepiride—KCNJ11—Neuronal System—SLC18A3—Alzheimer's disease	0.000938	0.0109	CbGpPWpGaD
Glimepiride—Abdominal pain—Memantine—Alzheimer's disease	0.000936	0.00152	CcSEcCtD
Glimepiride—Asthenia—Donepezil—Alzheimer's disease	0.000935	0.00152	CcSEcCtD
Glimepiride—Pruritus—Donepezil—Alzheimer's disease	0.000922	0.0015	CcSEcCtD
Glimepiride—Urticaria—Rivastigmine—Alzheimer's disease	0.00092	0.0015	CcSEcCtD
Glimepiride—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000915	0.00149	CcSEcCtD
Glimepiride—CYP2C9—Xenobiotics—CYP2D6—Alzheimer's disease	0.000897	0.0104	CbGpPWpGaD
Glimepiride—Diarrhoea—Donepezil—Alzheimer's disease	0.000892	0.00145	CcSEcCtD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—CREB1—Alzheimer's disease	0.000886	0.0103	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—INS—Alzheimer's disease	0.000881	0.0103	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—ACHE—Alzheimer's disease	0.000879	0.0102	CbGpPWpGaD
Glimepiride—Hypersensitivity—Memantine—Alzheimer's disease	0.000872	0.00142	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—CHRNA4—Alzheimer's disease	0.000869	0.0101	CbGpPWpGaD
Glimepiride—CYP2C9—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.000863	0.01	CbGpPWpGaD
Glimepiride—Dizziness—Donepezil—Alzheimer's disease	0.000862	0.0014	CcSEcCtD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—CREB1—Alzheimer's disease	0.000859	0.01	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—INS—Alzheimer's disease	0.000855	0.00995	CbGpPWpGaD
Glimepiride—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000853	0.00139	CcSEcCtD
Glimepiride—Asthenia—Memantine—Alzheimer's disease	0.000849	0.00138	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000842	0.0098	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.00084	0.00978	CbGpPWpGaD
Glimepiride—Pruritus—Memantine—Alzheimer's disease	0.000837	0.00136	CcSEcCtD
Glimepiride—Asthenia—Rivastigmine—Alzheimer's disease	0.000831	0.00135	CcSEcCtD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000829	0.00965	CbGpPWpGaD
Glimepiride—Vomiting—Donepezil—Alzheimer's disease	0.000829	0.00135	CcSEcCtD
Glimepiride—Rash—Donepezil—Alzheimer's disease	0.000822	0.00134	CcSEcCtD
Glimepiride—Dermatitis—Donepezil—Alzheimer's disease	0.000821	0.00134	CcSEcCtD
Glimepiride—Pruritus—Rivastigmine—Alzheimer's disease	0.000819	0.00133	CcSEcCtD
Glimepiride—Headache—Donepezil—Alzheimer's disease	0.000817	0.00133	CcSEcCtD
Glimepiride—ABCC8—Integration of energy metabolism—PLCB1—Alzheimer's disease	0.000813	0.00947	CbGpPWpGaD
Glimepiride—Diarrhoea—Memantine—Alzheimer's disease	0.00081	0.00132	CcSEcCtD
Glimepiride—KCNJ11—Type II diabetes mellitus—TNF—Alzheimer's disease	0.000806	0.00938	CbGpPWpGaD
Glimepiride—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000792	0.00129	CcSEcCtD
Glimepiride—KCNJ11—Integration of energy metabolism—PLCB1—Alzheimer's disease	0.000789	0.00918	CbGpPWpGaD
Glimepiride—Dizziness—Memantine—Alzheimer's disease	0.000783	0.00128	CcSEcCtD
Glimepiride—Nausea—Donepezil—Alzheimer's disease	0.000774	0.00126	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—BCHE—Alzheimer's disease	0.000766	0.00891	CbGpPWpGaD
Glimepiride—Dizziness—Rivastigmine—Alzheimer's disease	0.000766	0.00125	CcSEcCtD
Glimepiride—Vomiting—Memantine—Alzheimer's disease	0.000752	0.00123	CcSEcCtD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.00075	0.00873	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—DLG4—Alzheimer's disease	0.000747	0.0087	CbGpPWpGaD
Glimepiride—Rash—Memantine—Alzheimer's disease	0.000746	0.00122	CcSEcCtD
Glimepiride—Dermatitis—Memantine—Alzheimer's disease	0.000745	0.00121	CcSEcCtD
Glimepiride—Headache—Memantine—Alzheimer's disease	0.000741	0.00121	CcSEcCtD
Glimepiride—Vomiting—Rivastigmine—Alzheimer's disease	0.000736	0.0012	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—GRIN2B—Alzheimer's disease	0.000731	0.0085	CbGpPWpGaD
Glimepiride—Rash—Rivastigmine—Alzheimer's disease	0.00073	0.00119	CcSEcCtD
Glimepiride—Dermatitis—Rivastigmine—Alzheimer's disease	0.000729	0.00119	CcSEcCtD
Glimepiride—Headache—Rivastigmine—Alzheimer's disease	0.000725	0.00118	CcSEcCtD
Glimepiride—KCNJ1—Neuronal System—PLCB1—Alzheimer's disease	0.000723	0.00841	CbGpPWpGaD
Glimepiride—Nausea—Memantine—Alzheimer's disease	0.000703	0.00115	CcSEcCtD
Glimepiride—Nausea—Rivastigmine—Alzheimer's disease	0.000688	0.00112	CcSEcCtD
Glimepiride—ABCC8—Neuronal System—CHRNA7—Alzheimer's disease	0.000681	0.00793	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—GRIK1—Alzheimer's disease	0.000681	0.00793	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000681	0.00793	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—CHRNA7—Alzheimer's disease	0.000661	0.00769	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—GRIK1—Alzheimer's disease	0.000661	0.00769	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—GRIK2—Alzheimer's disease	0.000579	0.00674	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—CHAT—Alzheimer's disease	0.000579	0.00674	CbGpPWpGaD
Glimepiride—ABCC8—Regulation of insulin secretion—INS—Alzheimer's disease	0.000563	0.00656	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—GRIK2—Alzheimer's disease	0.000562	0.00654	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—CHAT—Alzheimer's disease	0.000562	0.00654	CbGpPWpGaD
Glimepiride—KCNJ11—Regulation of insulin secretion—INS—Alzheimer's disease	0.000546	0.00636	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—PRKCG—Alzheimer's disease	0.000534	0.00622	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.00052	0.00605	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—GRIA1—Alzheimer's disease	0.000516	0.00601	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000509	0.00592	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—GRIA1—Alzheimer's disease	0.000501	0.00583	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—CHRNB2—Alzheimer's disease	0.000489	0.00569	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—CHRNB2—Alzheimer's disease	0.000474	0.00552	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—CALM1—Alzheimer's disease	0.000462	0.00538	CbGpPWpGaD
Glimepiride—CYP2C9—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.00046	0.00536	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—ACHE—Alzheimer's disease	0.000449	0.00523	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—CHRNA4—Alzheimer's disease	0.000444	0.00517	CbGpPWpGaD
Glimepiride—ABCC8—Integration of energy metabolism—INS—Alzheimer's disease	0.000443	0.00516	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000442	0.00515	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—PTGS1—Alzheimer's disease	0.00044	0.00512	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—ACHE—Alzheimer's disease	0.000436	0.00507	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—CHRNA4—Alzheimer's disease	0.000431	0.00501	CbGpPWpGaD
Glimepiride—KCNJ11—Integration of energy metabolism—INS—Alzheimer's disease	0.000429	0.005	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000406	0.00473	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—CREB1—Alzheimer's disease	0.000396	0.00461	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—BCHE—Alzheimer's disease	0.000391	0.00456	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—DLG4—Alzheimer's disease	0.000382	0.00445	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—BCHE—Alzheimer's disease	0.000379	0.00442	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—GRIN2B—Alzheimer's disease	0.000373	0.00435	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000373	0.00434	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—DLG4—Alzheimer's disease	0.00037	0.00431	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—PLCB1—Alzheimer's disease	0.000369	0.0043	CbGpPWpGaD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000368	0.00428	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—GRIN2B—Alzheimer's disease	0.000362	0.00421	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP46A1—Alzheimer's disease	0.000362	0.00421	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—PLCB1—Alzheimer's disease	0.000358	0.00417	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000357	0.00415	CbGpPWpGaD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.000355	0.00414	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—DHCR24—Alzheimer's disease	0.000351	0.00409	CbGpPWpGaD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	0.000345	0.00401	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—DHCR24—Alzheimer's disease	0.000341	0.00397	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000308	0.00358	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000302	0.00352	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CA4—Alzheimer's disease	0.000299	0.00348	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000292	0.00339	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CA4—Alzheimer's disease	0.00029	0.00337	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GAPDHS—Alzheimer's disease	0.000281	0.00327	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000278	0.00323	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—PRKCG—Alzheimer's disease	0.000273	0.00318	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GAPDHS—Alzheimer's disease	0.000272	0.00317	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ATP5A1—Alzheimer's disease	0.000266	0.0031	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—PRKCG—Alzheimer's disease	0.000265	0.00308	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ATP5A1—Alzheimer's disease	0.000258	0.00301	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PLD3—Alzheimer's disease	0.000254	0.00296	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PLD3—Alzheimer's disease	0.000246	0.00287	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HSD17B10—Alzheimer's disease	0.000244	0.00283	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—CALM1—Alzheimer's disease	0.000236	0.00275	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HSD17B10—Alzheimer's disease	0.000236	0.00275	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000236	0.00275	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP46A1—Alzheimer's disease	0.000234	0.00273	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—CALM1—Alzheimer's disease	0.000229	0.00267	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP46A1—Alzheimer's disease	0.000227	0.00265	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ND1—Alzheimer's disease	0.000226	0.00264	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ND1—Alzheimer's disease	0.00022	0.00256	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—MAOB—Alzheimer's disease	0.000216	0.00251	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—DHCR24—Alzheimer's disease	0.000208	0.00242	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—CREB1—Alzheimer's disease	0.000202	0.00235	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—CREB1—Alzheimer's disease	0.000196	0.00228	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—PTGS2—Alzheimer's disease	0.000168	0.00196	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000165	0.00192	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—PTGS1—Alzheimer's disease	0.000164	0.0019	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP2D6—Alzheimer's disease	0.00016	0.00187	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000158	0.00184	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PLD3—Alzheimer's disease	0.000151	0.00175	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—TPI1—Alzheimer's disease	0.000146	0.0017	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CHAT—Alzheimer's disease	0.000146	0.0017	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—TPI1—Alzheimer's disease	0.000141	0.00165	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CHAT—Alzheimer's disease	0.000141	0.00165	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MAOB—Alzheimer's disease	0.00014	0.00163	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP46A1—Alzheimer's disease	0.000139	0.00162	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MAOB—Alzheimer's disease	0.000136	0.00158	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GAPDH—Alzheimer's disease	0.000135	0.00157	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GAPDH—Alzheimer's disease	0.000131	0.00152	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—A2M—Alzheimer's disease	0.00013	0.00151	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—A2M—Alzheimer's disease	0.000126	0.00147	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ACHE—Alzheimer's disease	0.000113	0.00132	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—INPP5D—Alzheimer's disease	0.000112	0.0013	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ACHE—Alzheimer's disease	0.00011	0.00128	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—INPP5D—Alzheimer's disease	0.000108	0.00126	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ENO1—Alzheimer's disease	0.000106	0.00123	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTGS1—Alzheimer's disease	0.000106	0.00123	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP2D6—Alzheimer's disease	0.000104	0.00121	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTGS1—Alzheimer's disease	0.000103	0.0012	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ENO1—Alzheimer's disease	0.000103	0.0012	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP2D6—Alzheimer's disease	0.000101	0.00117	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—BCHE—Alzheimer's disease	9.85e-05	0.00115	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—BCHE—Alzheimer's disease	9.56e-05	0.00111	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PLCB1—Alzheimer's disease	9.3e-05	0.00108	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—DHCR24—Alzheimer's disease	9.27e-05	0.00108	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PLCB1—Alzheimer's disease	9.02e-05	0.00105	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCA1—Alzheimer's disease	9.01e-05	0.00105	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCA1—Alzheimer's disease	8.74e-05	0.00102	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	8.65e-05	0.00101	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CA4—Alzheimer's disease	7.88e-05	0.000918	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPARGC1A—Alzheimer's disease	7.77e-05	0.000904	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—HMOX1—Alzheimer's disease	7.73e-05	0.0009	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	7.71e-05	0.000897	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPARGC1A—Alzheimer's disease	7.53e-05	0.000877	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—HMOX1—Alzheimer's disease	7.5e-05	0.000873	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GAPDHS—Alzheimer's disease	7.41e-05	0.000863	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LPL—Alzheimer's disease	7.07e-05	0.000823	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	7.03e-05	0.000818	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LPL—Alzheimer's disease	6.86e-05	0.000798	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PLD3—Alzheimer's disease	6.7e-05	0.00078	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	6.7e-05	0.00078	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	6.63e-05	0.000771	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	6.43e-05	0.000748	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—MTHFR—Alzheimer's disease	6.37e-05	0.000741	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	6.28e-05	0.000731	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	6.19e-05	0.00072	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—MTHFR—Alzheimer's disease	6.17e-05	0.000719	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ND1—Alzheimer's disease	5.98e-05	0.000695	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CALM1—Alzheimer's disease	5.95e-05	0.000692	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APOE—Alzheimer's disease	5.93e-05	0.00069	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CAV1—Alzheimer's disease	5.87e-05	0.000684	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	5.84e-05	0.00068	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CALM1—Alzheimer's disease	5.77e-05	0.000671	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APOE—Alzheimer's disease	5.75e-05	0.000669	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CAV1—Alzheimer's disease	5.7e-05	0.000663	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	5.34e-05	0.000622	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPARG—Alzheimer's disease	5.16e-05	0.000601	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—INS—Alzheimer's disease	5.06e-05	0.00059	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPARG—Alzheimer's disease	5.01e-05	0.000583	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—INS—Alzheimer's disease	4.91e-05	0.000572	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	4.6e-05	0.000536	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—NOS3—Alzheimer's disease	4.44e-05	0.000517	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—NOS3—Alzheimer's disease	4.31e-05	0.000501	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	4.19e-05	0.000488	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTGS2—Alzheimer's disease	4.06e-05	0.000473	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTGS2—Alzheimer's disease	3.94e-05	0.000458	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—TPI1—Alzheimer's disease	3.85e-05	0.000448	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CHAT—Alzheimer's disease	3.85e-05	0.000448	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MAOB—Alzheimer's disease	3.69e-05	0.00043	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	3.55e-05	0.000414	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	3.51e-05	0.000409	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	3.48e-05	0.000405	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—A2M—Alzheimer's disease	3.43e-05	0.000399	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	3.06e-05	0.000356	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ACHE—Alzheimer's disease	2.99e-05	0.000348	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	2.95e-05	0.000343	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	2.8e-05	0.000326	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ENO1—Alzheimer's disease	2.8e-05	0.000326	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	2.74e-05	0.000319	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—BCHE—Alzheimer's disease	2.6e-05	0.000303	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	2.45e-05	0.000286	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	2.41e-05	0.00028	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	2.38e-05	0.000277	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	2.05e-05	0.000239	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—AKT1—Alzheimer's disease	2.04e-05	0.000238	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	2.04e-05	0.000238	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—AKT1—Alzheimer's disease	1.98e-05	0.00023	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LPL—Alzheimer's disease	1.87e-05	0.000217	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	1.68e-05	0.000196	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CALM1—Alzheimer's disease	1.57e-05	0.000183	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APOE—Alzheimer's disease	1.56e-05	0.000182	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CAV1—Alzheimer's disease	1.55e-05	0.00018	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPARG—Alzheimer's disease	1.36e-05	0.000159	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—INS—Alzheimer's disease	1.34e-05	0.000156	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.17e-05	0.000136	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.07e-05	0.000125	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—AKT1—Alzheimer's disease	5.39e-06	6.27e-05	CbGpPWpGaD
